Loading
Latest filing published 16 May 2019 for Tetra Bio-Pharma Inc..
No signal scores available.
Gregory John Drohan discloses dealings in Tetra Bio-Pharma Inc. to SEDI. Over a trading history stretching from 10 April 2018 to 1 May 2019, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 16 May 2019 came the latest disclosure, a transaction in Tetra Bio-Pharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations